K2M’s President and CEO Eric Major noted in the report, “FDA clearance of MESA 2 is a milestone event for K2M that further enhances our position in the global spine surgery market.” The MESA 2 is the next generation of the company’s established MESA spinal device.
To learn more about K2M and their wide variety of medical devices, click here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
